Home » Newsletters » BioWorld Science

BioWorld Science

July 3, 2002

View Archived Issues

Baxter submits BLA for rAHF-PFM

Atrix files IND for transmucosal sumatriptan

Nolvadex warnings strengthened

Immune Network presents overview of drug candidate development

Fujisawa seeks Canadian approval for micafungin

Hepatitis B pharmaccine enters phase II

PS-1145 reduces multiple myeloma growth and survival through inhibition of NF-kB activation

Selective glucocorticoid receptor antagonist demonstrates clinical antidepressant activity

Traditional medicinal products with potential in Alzheimer's disease

New IL-4 variant evaluated for safety in phase I trial in MS patients

Favorable NMB characteristics determined for TAAC3 in animals

Pretreatment with Genasense being tested for advanced malignant melanoma

In vitro evidence for efficacy of bosentan in malignant melanoma presented in Paris

Resiquimod prevents recurrence of genital herpes

Selective Lys-gingipain inhibitors for use in periodontitis

Ajinomoto presents novel SGLT2 inhibitors

New PGD2 antagonists for use in upper respiratory tract disorders

Novel analgesic naphthyridines identified at Otsuka

Takeda reports novel CCR5 antagonists and their use in HIV infection

Nociceptin receptor ligands claimed by Nippon Shinyaku

Fampridine-SR enters two phase III trials for chronic spinal cord injury

Inhibitors of NF-kB activation and their use in inflammatory disorders

HuMax-IL-15 effective in mouse model of psoriasis

NeoPharm submits IND for LE-SN-38

CPMP recommends approval of new indication for clopidogrel

Nonapprovable letter issued for Risperdal Consta

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...